Aldevron is formerly owned by EQT, through EQT VIII, since 2019.

When did EQT acquire Aldevron?

EQT acquired Aldevron in 2019 and exited after 2 years.

Has Aldevron been sold?

Yes. Aldevron was exited in 2021 via Trade Sale.

Home/Companies/Biotech/Aldevron

Aldevron

Biotech·

US·Exited 2021·Held 2yr

Entry

2019

Hold

2yr

Exit

2021

Who owns Aldevron?

Aldevron was owned by EQT through EQT VIII (2018 vintage) from 2019 to 2021, exited via Trade Sale. Across its history, Aldevron has been through 2 private equity ownership periods, detailed in the timeline below.

Buyer identity available on Pro.

Hand-verified · updated 2026-04-21

Most recent investor

EQT

EQT VIII · 2018 · Buyout

2 ownership periods · full history below

Key facts

HQUSA

SectorBiotech

Websitewww.aldevron.com

Ownership history

2 ownership periods

Active

Currently held by TA Associates.

EQTExited 2021

2019 · 2021(2yr) · EQT VIII · 2018 · Buyout

Trade Sale · to

MOIC

–

TA AssociatesActive

present · TA Associates Portfolio · Buyout

More from EQT VIII

Other portfolio companies in the same fund.

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare

Active

The Carlyle GroupChina

Adagene

Active

General AtlanticChina

Advanced Cell Diagnostics

Track Aldevron

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Aldevron?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Aldevron.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment

Save this company to your watchlist

Exit buyer and MOIC on this deal (Pro)

Continue with email

Already a member? Sign in

Look up another firm or company

Data refreshed weekly · Sourced from public filings · Report an issue